Comparison of the Safety and Tolerance Profile of Micafungin with that of Other Echinocandins and Azoles in Patients with Pre-existing Child –Pugh B or C Liver Disease: A Case–Control Retrospective Study
ConclusionsOur study suggests that the administration of micafungin to patients with end-stage liver disease does not imply a higher risk of developing STLI or LTLI.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
More News: Child Development | Children | Infectious Diseases | Italy Health | Liver | Liver Disease | Liver Transplant | Spain Health | Study | Transplants | Urology & Nephrology